Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides

Supporting evidence

• Evaluation report

• Final appraisal determination committee papers (PDF 1.32 MB)

  Published:

  13 July 2022

• Appraisal consultation 1 committee papers (PDF 4.1 MB)

  Published:

  13 July 2022

• Appraisal consultation 2 committee papers (PDF 2.01 MB)

  Published:

  13 July 2022